Skip to main content
. 2022 Sep 19;199(5):728–738. doi: 10.1111/bjh.18459

TABLE 3.

Prevalence per million persons of Langerhans cell histiocytosis in England on 31 December 2019

N (%) a of people diagnosed with LCH in 2013–2019 and still alive at the end of 2019 Prevalence (95% CI)
Age on 31 December 2019, years
Infants (<1) 2 (0) 3.23 (0.39–11.67)
1–14 280 (50) 29.25 (25.92–32.88)
15–29 81 (14) 7.80 (6.20–9.70)
30–44 66 (12) 6.02 (4.66–7.66)
45–59 79 (14) 6.99 (5.54–8.72)
≥60 52 (9) 3.86 (2.88–5.06)
Children (<15) 282 (50) 27.67 (24.53–31.09)
Adults (≥15) 278 (50) 6.03 (5.34–6.78)
Overall 560 (100) 9.95 (9.14–10.81)
Sex
Female 245 (44) 8.61 (7.56–9.76)
Male 315 (56) 11.32 (10.10–12.64)
Deprivation quintile
1 – least deprived 101 (18) 9.27 (7.55–11.26)
2 94 (17) 8.46 (6.83–10.35)
3 98 (18) 8.58 (6.96–10.45)
4 130 (23) 11.23 (9.38–13.33)
5 – most deprived 137 (24) 12.16 (10.21–14.37)
Region
North East 26 (5) 9.74 (6.36–14.27)
North West 62 (11) 8.45 (6.48–10.83)
Yorkshire/Humber 53 (9) 9.63 (7.21–12.60)
East Midlands 37 (7) 7.65 (5.39–10.55)
West Midlands 77 (14) 12.98 (10.24–16.22)
East of England 50 (9) 8.02 (5.95–10.57)
London 80 (14) 8.93 (7.08–11.11)
South East 104 (19) 11.33 (9.26–13.73)
South West 71 (13) 12.62 (9.86–15.92)

Abbreviations: CI, confidence interval; LCH, Langerhans cell histiocytosis. a :Percentages might not total 100% due to approximation.